Does placebo help establish equivalence in trials of new antidepressants? (Q51974677)

19 April 2018

title

Does placebo help establish equivalence in trials of new antidepressants? (English)

1 reference

19 April 2018

1 reference

Barbui C

1

1 reference

19 April 2018

Violante A

series ordinal

2

1 reference

19 April 2018

Garattini S

series ordinal

3

1 reference

19 April 2018

language of work or name

English

0 references

publication date

1 June 2000

1 reference

19 April 2018

published in

European Psychiatry

1 reference

19 April 2018

volume

15

1 reference

19 April 2018

page(s)

268-273

1 reference

19 April 2018

issue

4

1 reference

19 April 2018

ABC of mental health. Depression

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

ABC of mental health. Psychotropic drug treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

When are placebo-controlled trials no longer appropriate?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Placebo-controlled trials: when are they needed?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Sample size and power in psychiatric research.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Trials to assess equivalence: the importance of rigorous methods

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Antidepressant treatment of depression: a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

The number needed to treat: a clinically useful measure of treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

The continuing unethical use of placebo controls

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Use and abuse of placebo in phase III trials

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Putting trials on trial--the costs and consequences of small trials in depression: a systematic review of methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Antidepressant agents: from tricyclics to serotonin uptake inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Choosing the best research design for each question

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Statistics and ethics in medical research: III How large a sample?

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Absence of evidence is not evidence of absence

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

When placebo controlled trials are essential and equivalence trials are inadequate

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

The Antidepressant Web: Marketing depression and making medicines work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

The three faces of the antidepressants: a critical commentary on the clinical-economic context of diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

Pragmatic randomised controlled trials in psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

A double-blind, placebo-controlled comparison of sertraline and dothiepin in the treatment of major depression in general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

A comparative clinical trial of fluoxetine, mianserin and placebo in depressed outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-9338%2800%2900233-9

7 January 2021

10.1016/S0924-9338(00)00233-9

Identifiers

DOI

1 reference

19 April 2018

PubMed ID

10951612

1 reference

19 April 2018